| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.0903573 |
| P8608 | Fatcat ID | release_wnclufbqcnfsfgie7vwb3ub5iu |
| P698 | PubMed publication ID | 20525890 |
| P5875 | ResearchGate publication ID | 44651852 |
| P50 | author | Michael Manns | Q1564831 |
| P2093 | author name string | Tim F Greten | |
| Firouzeh Korangy | |||
| Lydia A Haile | |||
| Jaba Gamrekelashvili | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 203-210 | |
| P577 | publication date | 2010-06-04 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice | |
| P478 | volume | 185 |
| Q34365909 | A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice |
| Q35685541 | Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis |
| Q35566772 | Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells |
| Q35970518 | An Immature Myeloid/Myeloid-Suppressor Cell Response Associated with Necrotizing Inflammation Mediates Lethal Pulmonary Tularemia |
| Q37078946 | Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma |
| Q36410807 | Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. |
| Q58695193 | Bone marrow mesenchymal stem cells tune the differentiation of myeloid-derived suppressor cells in bleomycin-induced lung injury |
| Q50893610 | CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice. |
| Q36490660 | Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma |
| Q36338435 | Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing mice |
| Q35509317 | Complexity and challenges in defining myeloid-derived suppressor cells |
| Q28395157 | Coordinated regulation of myeloid cells by tumours |
| Q37822746 | Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity |
| Q47863413 | Deficiency of KLF4 compromises the lung function in an acute mouse model of allergic asthma |
| Q36456466 | Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activity |
| Q36967364 | Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. |
| Q47677887 | Does CSF1R Blockade Turn into Friendly Fire? |
| Q27340196 | EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer |
| Q47808999 | Expansion of CD11b+Ly6Ghigh and CD11b+CD49d+ myeloid cells with suppressive potential in mice with chronic inflammation and light-at-night-induced circadian disruption |
| Q36456474 | Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients |
| Q50919779 | Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice. |
| Q35958016 | Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice |
| Q41898259 | Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells |
| Q38141522 | History of myeloid-derived suppressor cells |
| Q34076238 | IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1. |
| Q38047049 | Immune suppression: the hallmark of myeloid derived suppressor cells. |
| Q33848077 | Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation |
| Q36497982 | Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function |
| Q38492085 | Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases |
| Q90058310 | Kidney injury enhances renal G-CSF expression and modulates granulopoiesis and human neutrophil CD177 in vivo |
| Q35470164 | Kruppel-like factor KLF4 facilitates cutaneous wound healing by promoting fibrocyte generation from myeloid-derived suppressor cells. |
| Q29618033 | Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy |
| Q37839314 | MDSC in autoimmunity |
| Q26741252 | Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation |
| Q37832442 | Myeloid cell diversification and complexity: an old concept with new turns in oncology |
| Q42408323 | Myeloid cells in tumor inflammation |
| Q58789294 | Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation |
| Q89976160 | Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer |
| Q89613164 | Myeloid-Derived Suppressor Cells in the Tumor Microenvironment |
| Q38223250 | Myeloid-derived suppressor cell heterogeneity in human cancers |
| Q48215791 | Myeloid-derived suppressor cells coming of age. |
| Q37727645 | Myeloid-derived suppressor cells in gliomas |
| Q38005601 | Myeloid-derived suppressor cells in transplantation and cancer |
| Q37019136 | Myeloid-derived suppressor cells: natural regulators for transplant tolerance |
| Q38047048 | Negative regulation of myeloid-derived suppressor cells in cancer |
| Q35850754 | Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans |
| Q42493330 | Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways |
| Q28079046 | Phenotype, development, and biological function of myeloid-derived suppressor cells |
| Q37222105 | Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice. |
| Q37248887 | Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma |
| Q60046853 | Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis |
| Q34150479 | S100A9 a new marker for monocytic human myeloid-derived suppressor cells. |
| Q58130125 | Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab |
| Q28080262 | Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy |
| Q90989337 | Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b+Gr-1+ cell expansion and inhibits lymphocyte infiltration in the lungs to ameliorate murine pulmonary emphysema |
| Q37692764 | Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways |
| Q37681488 | Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients |
| Q39218352 | T helper type 17 cells contribute to anti-tumour immunity and promote the recruitment of T helper type 1 cells to the tumour. |
| Q84474553 | Targeting myeloid regulatory cells in cancer by chemotherapeutic agents |
| Q38791223 | The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer |
| Q35750663 | The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity |
| Q36998125 | The impact of ranitidine on monocyte responses in the context of solid tumors. |
| Q50981184 | Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis. |
| Q35586581 | Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner |
Search more.